Your browser doesn't support javascript.
loading
Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.
Riedell, Peter A; Hamadani, Mehdi; Ahn, Kwang W; Litovich, Carlos; Murthy, Guru Subramanian Guru; Locke, Frederick L; Brunstein, Claudio G; Merryman, Reid W; Stiff, Patrick J; Pawarode, Attaphol; Nishihori, Taiga; Kharfan-Dabaja, Mohamed A; Herrera, Alex F; Sauter, Craig S; Smith, Sonali M.
Afiliación
  • Riedell PA; Division of Hematology and Oncology, University of Chicago Medicine, Chicago, Illinois.
  • Hamadani M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: mhamadani@mcw.edu.
  • Ahn KW; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Litovich C; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Murthy GSG; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Brunstein CG; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota.
  • Merryman RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Masachusetts.
  • Stiff PJ; Division of Hematology-Oncology, Department of Medicine, Loyola University Stritch School of Medicine, Maywood, Illinois.
  • Pawarode A; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.
  • Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.
  • Sauter CS; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Smith SM; Division of Hematology and Oncology, University of Chicago Medicine, Chicago, Illinois.
Transplant Cell Ther ; 27(11): 911.e1-911.e7, 2021 11.
Article en En | MEDLINE | ID: mdl-34450333
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Linfoma de Células del Manto Tipo de estudio: Observational_studies Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Linfoma de Células del Manto Tipo de estudio: Observational_studies Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article